Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient

  • Marco Antonio Yamazaki-Nakashimada Department of Pediatric Clinical Immunology, Instituto Nacional de Pediatria. Mexico City, Mexico
  • Patricia Herrera-Mora Department of Pediatric Neurology, Instituto Nacional de Pediatria. Mexico City, Mexico
  • Alfonso Mahrx-Bracho Department of Pediatric Neurosurgery, Instituto Nacional de Pediatria. Mexico City, Mexico
  • Gabriela López-Herrera Immunodeficiencies Research Unit, Instituto Nacional de Pediatria. Mexico City, Mexico
  • Juan Carlos Bustamante-Ogando Immunodeficiencies Research Unit, Instituto Nacional de Pediatria. Mexico City, Mexico
  • Selma Cecilia Scheffler-Mendoza Department of Pediatric Clinical Immunology, Instituto Nacional de Pediatria. Mexico City, Mexico
Keywords: Agammaglobulinemia; Immunomodulators; Primary immunodeficiency diseases; Neuroinflammatory diseases; Therapy

Abstract

Most patients with X-linked agammaglobulinemia are susceptible to infections, while some cases also suffer from inflammatory or autoimmune complications. We describe a patient with progressive encephalitis who improved after the use of immunomodulatory treatment with corticosteroids, fluoxetine, and nitazoxanide. In most of the cases the evolution of the progressive encephalitis is complicated and catastrophic. Based on our experience and the review of the literature, we propose the use of this combined treatment to control this devastating complication.

Published
2023-11-07
Section
Articles